BackBright Minds Biosciences Overview

Bright Minds Biosciences Goodwill

Track Bright Minds Biosciences's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average

Loading

Bright Minds Biosciences Goodwill History

Loading

Bright Minds Biosciences vs. peers: Goodwill Comparison

Loading

Bright Minds Biosciences Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bright Minds Biosciences (DRUG) FAQ

Bright Minds Biosciences (DRUG) currently reports a goodwill of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bright Minds Biosciences's goodwill history and peer comparisons.

Bright Minds Biosciences's goodwill changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bright Minds Biosciences reported $0 in goodwill as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bright Minds Biosciences, and consider following DRUG for alerts when major investors trade the stock.

Bright Minds Biosciences is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DRUG with unrelated industries.